Hormone replacement therapy, including bioidentical hormone therapy, is one option for managing the symptoms of perimenopause and menopause: hot flashes, night sweats, vaginal dryness, irritability, brain fog and sleep that never quite finishes. It is not right for everyone. Your personal and family medical history, your current medications and your own priorities all factor into the decision, and a physician at our office will walk through them with you before anything is prescribed.
North Druid Hills is a community where a lot of people already read the literature. Patients often come in having compared notes with a colleague at Emory, a friend at synagogue near Toco Hill, or a sister-in-law who had a very different experience. We welcome that. Bring the questions and the articles. Part of the visit is separating what applies to your situation from what does not, and being honest about what is known and what is still debated.
The trip is an easy one to fold into an existing errand. Patients generally run North Druid Hills Road (SR 42) out to I-85, head north to GA-400, and exit toward Lenox Road or Wieuca Road to reach Roswell Road NE. Our hours are Monday through Thursday 9 to 6 and Friday 9 to 4, and a follow-up call to (404) 341-4819 can usually sort out a question without another drive.
About Hormone Replacement Therapy
Hormone replacement therapy restores hormones the body has stopped producing in adequate amounts. For women, that usually means estrogen, often paired with progesterone, prescribed for hot flashes, night sweats, disrupted sleep, vaginal dryness, and the mood and concentration changes that can accompany perimenopause and menopause. For men, it usually means testosterone, prescribed when blood testing confirms low levels alongside symptoms such as persistent fatigue, low libido, loss of muscle mass, or low mood. The two are different treatments with different protocols, different monitoring, and different risks, but they share one principle: hormones are prescription medications, and the decision to start them belongs to a physician who has examined you and reviewed your labs.
At Atlanta Medical Institute, hormone therapy begins with evaluation rather than a product. That means a symptom history, a review of your medical and family history, a physical exam, and bloodwork appropriate to what is being considered. Some people who arrive convinced their hormones are the problem turn out to have thyroid disease, sleep apnea, anemia, depression, or a medication side effect driving the symptoms instead. Finding that out first matters, because treating the wrong thing wastes months and leaves the real cause unaddressed.
The clinical picture around hormone therapy has changed meaningfully in recent years. In November 2025, the FDA began removing the boxed warnings related to cardiovascular disease, breast cancer, and probable dementia from menopausal hormone therapy labeling, reflecting a reassessment of the older Women's Health Initiative data and a better understanding of how age at initiation affects risk. In early 2025 the FDA also updated labeling across testosterone products to include results from the TRAVERSE cardiovascular safety trial along with a new warning about increases in blood pressure. None of this makes hormone therapy risk-free or right for everyone. It does mean the conversation is more nuanced than it was a decade ago, and it is worth having with a physician rather than settling from a headline.
What hormone replacement therapy actually involves
For women, systemic estrogen is the most effective available treatment for hot flashes and night sweats. It can be delivered orally or transdermally through a patch, gel, or spray. The route matters clinically: transdermal estradiol bypasses first-pass liver metabolism, and observational and comparative data suggest it carries a lower risk of blood clots than oral estrogen, which is one reason it is often preferred for women with clotting risk factors. If you still have a uterus, estrogen is prescribed with a progestogen to protect the endometrial lining. Micronized progesterone is frequently chosen because its safety profile compares favorably with older synthetic progestins. Women whose only bothersome symptom is vaginal dryness or painful intercourse are often better served by low-dose vaginal estrogen, which acts locally with minimal systemic absorption.
For men, testosterone replacement is available as topical gels, injections, oral formulations, and implanted pellets. Each has tradeoffs in dosing stability, convenience, and cost, and the right choice depends on your labs, your schedule, and your tolerance. Testosterone products are approved for men with low testosterone caused by an identifiable medical condition, and the FDA label specifically notes they are not approved for low testosterone due solely to aging. That distinction shapes how a careful physician evaluates and documents a case.
You will also hear the term bioidentical, which describes hormones with the same molecular structure as those the body makes. Estradiol and micronized progesterone are bioidentical and are available in FDA-approved, standardized products. Custom-compounded bioidentical preparations are a separate category. The National Academies of Sciences, Engineering, and Medicine reviewed the evidence and concluded there is not sufficient data to show compounded preparations are as safe or as effective as FDA-approved hormone therapy, and studies of compounded pellets in particular have found wide variation in the hormone levels they produce. Your physician can explain where a given option falls and why.
- Estrogen: oral tablets, transdermal patches, gels, sprays, and low-dose vaginal preparations
- Progestogen for women with a uterus, most often micronized progesterone, to protect the endometrium
- Testosterone: topical gels, intramuscular or subcutaneous injections, oral formulations, and pellets
- Baseline laboratory testing before any prescription is written
- Scheduled follow-up labs and dose adjustment rather than a fixed, set-and-forget dose
Who may be a candidate
For women, the clearest indication remains bothersome vasomotor symptoms, meaning hot flashes and night sweats significant enough to disrupt sleep, work, or daily life. Genitourinary symptoms and prevention of bone loss in women at elevated fracture risk are also recognized indications. Timing carries real weight in the current evidence: the favorable benefit-risk balance is strongest for women who begin therapy before age 60 or within ten years of their final menstrual period. Women further out from menopause are not automatically excluded, but the calculation is different and deserves a longer conversation.
For men, candidacy rests on symptoms plus confirmed low testosterone on blood testing, not on symptoms alone. Testosterone follows a daily rhythm, so levels are drawn in the morning and generally confirmed on a second separate occasion before a diagnosis is made. A low-normal number in a man with no symptoms is not by itself a reason to treat, and a man with classic symptoms and repeatedly normal testosterone needs a different workup, not a prescription.
Certain histories make hormone therapy inadvisable or require specialist input first. For women, these include a history of breast cancer or estrogen-dependent cancer, unexplained vaginal bleeding, prior stroke or heart attack, active liver disease, and a history of blood clots. For men, these include untreated prostate cancer, elevated hematocrit, untreated severe sleep apnea, poorly controlled heart failure, and a desire to conceive in the near term, since testosterone therapy suppresses sperm production. Your physician will determine whether treatment is appropriate for you after reviewing your full history.
- Persistent hot flashes, night sweats, and sleep disruption during perimenopause or menopause
- Vaginal dryness, irritation, or pain with intercourse
- Early or surgical menopause, where hormone therapy is often recommended until the typical age of natural menopause
- Men with symptoms of low testosterone confirmed on repeat morning blood testing
- Anyone whose symptoms have not been explained by thyroid disease, sleep disorder, medication effect, or another treatable condition
What to expect, from first visit through follow-up
The first visit is an evaluation, not a sales appointment. Expect a detailed symptom history, questions about your menstrual or reproductive history, a review of medications and supplements, family history of breast cancer, heart disease, and clotting disorders, a physical exam, and blood pressure. Lab work is ordered based on what is being considered. For women, that may include thyroid function, a metabolic panel, lipids, and sometimes estradiol and FSH, though menopause is often diagnosed clinically rather than by a lab number. For men, it includes morning total testosterone, typically repeated, along with a complete blood count, PSA for men over 40, and often LH, prolactin, and estradiol to understand the cause of the low level.
If therapy is appropriate, your physician will start at a conservative dose and adjust from there. Symptom relief is usually gradual. Many women notice improvement in hot flashes within a few weeks, though full benefit and the right dose can take a couple of months to settle. Men on testosterone often report changes in energy and mood before changes in body composition, which take considerably longer and depend heavily on what you do with diet and training. Some people feel little difference at first, and that is information too. It may mean a dose adjustment, a change in delivery method, or a reconsideration of whether hormones are the right answer.
Follow-up is not optional and it is not a formality. Expect repeat labs and a check-in within the first few months of starting, then at regular intervals once you are stable. Bring up side effects early rather than waiting. Breast tenderness, breakthrough bleeding, mood changes, acne, fluid retention, and irritability are all things that often respond to a dose or formulation change if your physician knows about them.
Safety, monitoring, and the honest limits
Hormone therapy is prescription medicine with real risks, and the point of supervision is to catch problems while they are still small. For women on systemic estrogen, monitoring includes blood pressure, continued age-appropriate breast cancer screening, and prompt evaluation of any unexpected vaginal bleeding. The FDA's 2025 labeling changes removed several boxed warnings, but the endometrial cancer boxed warning remains on systemic estrogen-alone products, which is precisely why women with a uterus are prescribed a progestogen alongside estrogen.
For men on testosterone, monitoring centers on hematocrit, PSA, and blood pressure. Testosterone can thicken the blood, and a rising hematocrit is a recognized reason to lower the dose, extend the interval, or pause therapy while the cause is investigated. PSA is followed in men over 40. The FDA's 2025 update added a class-wide warning about increases in blood pressure based on ambulatory monitoring studies, so blood pressure is checked rather than assumed. The TRAVERSE trial, which enrolled more than 5,000 men with hypogonadism at elevated cardiovascular risk, found testosterone noninferior to placebo for major adverse cardiac events, but also observed more atrial fibrillation and pulmonary embolism in the testosterone group. That is the fuller picture, and it belongs in the conversation.
What hormone therapy cannot do is worth stating plainly. It is not an anti-aging program, it is not a guarantee of any particular outcome, and it does not replace sleep, nutrition, strength training, or treatment of conditions like hypertension and diabetes. Anyone promising you a specific result is telling you something medicine cannot support. What a physician can offer is a careful evaluation, an evidence-based plan, honest discussion of what is known and unknown, and ongoing monitoring with a willingness to change course.
- Blood pressure at every visit for both men and women on hormone therapy
- Hematocrit and PSA monitoring for men on testosterone, with dose changes if hematocrit rises
- Continued mammography and age-appropriate screening for women, unchanged by being on therapy
- Prompt evaluation of unexpected vaginal bleeding, new leg swelling or pain, chest pain, or severe headache
- Periodic reassessment of whether continuing therapy still makes sense for you
Getting Here from North Druid Hills
Patients typically take North Druid Hills Road (SR 42) west to I-85, then head north to GA-400 and exit toward Lenox Road or Wieuca Road, crossing over to Roswell Road NE just south of Chastain Park; drivers coming from the Toco Hills side often use LaVista Road or Briarcliff Road to reach I-85 instead.
5009 Roswell Road NE, Suite 201
Atlanta, GA 30342
We see patients from across North Druid Hills and nearby areas including Toco Hills, Briarcliff, Medlock Park, North Druid Woods, Executive Park.
Hormone Replacement Therapy in North Druid Hills — Frequently Asked Questions
What is the difference between HRT and bioidentical hormone therapy?
Bioidentical hormones are formulated to match the molecular structure of hormones the body produces. Conventional hormone therapy may use other preparations. Both are used to manage menopause symptoms, and your physician will explain the differences, the evidence, and which approach fits your history.
Is hormone therapy safe for me?
That depends on your individual history, including cardiovascular risk, cancer history and other conditions. There is no universal answer. A physician determines candidacy after a medical evaluation, and for some women a non-hormonal approach is the better recommendation.
How far is your office from the Toco Hills area?
Our only office is at 5009 Roswell Road NE, Suite 201, in Atlanta. From Toco Hills most patients take LaVista Road or Briarcliff Road to I-85, then GA-400 north and exit toward Lenox or Wieuca Road.
Is hormone replacement therapy safe?
Safety depends on which hormone, which route, your age, how long since menopause, and your personal medical history, which is why there is no single answer that applies to everyone. The FDA began removing several boxed warnings from menopausal hormone therapy labeling in November 2025, reflecting a reassessment of the older data, and the benefit-risk balance is generally most favorable for women who start before age 60 or within ten years of menopause. Real risks remain for some patients, including women with a history of breast cancer, blood clots, stroke, or liver disease. A physician will review your history and labs and tell you honestly whether it is a reasonable option for you.
How do I know if my testosterone is actually low?
Symptoms alone are not enough, because fatigue, low libido, weight gain, and low mood have many causes. Diagnosis requires a morning blood draw, since testosterone follows a daily rhythm, and the result is generally confirmed on a second separate occasion before treatment is considered. Additional testing often includes a complete blood count, PSA for men over 40, and hormones such as LH and prolactin to understand why the level is low. Some men who come in expecting a testosterone prescription turn out to have untreated sleep apnea, thyroid disease, or a medication effect instead.
What is the difference between bioidentical hormones and regular HRT?
Bioidentical describes hormones that match the molecular structure of those the body produces, such as estradiol and micronized progesterone. Both are available in FDA-approved, standardized products, so bioidentical and FDA-approved are not opposites. The meaningful distinction is between FDA-approved products and custom-compounded preparations. The National Academies of Sciences, Engineering, and Medicine reviewed the evidence and found insufficient data to conclude that compounded preparations are as safe or effective as FDA-approved hormone therapy, and studies of compounded pellets have shown wide variation in the hormone levels they deliver. Your physician can explain which category any recommended option falls into.
How long will it take before I feel different?
It varies, and gradual is normal. Many women notice hot flashes and night sweats improving within a few weeks of starting estrogen, though finding the right dose can take a couple of months. Vaginal symptoms treated with local estrogen often improve over several weeks. Men starting testosterone frequently report changes in energy, mood, and libido before any change in body composition, which develops more slowly and depends significantly on nutrition and resistance training. If you feel no difference after a reasonable trial, that is worth reporting, since it may call for a dose change, a different delivery method, or a rethink of the diagnosis.
Do I have to stay on hormone therapy forever?
No. Hormone therapy is reassessed periodically rather than continued indefinitely by default. Some women use it for a few years through the most disruptive part of the menopause transition and then taper off; others, after weighing benefits and risks with their physician, continue longer. Women with early or surgical menopause are often advised to continue until roughly the typical age of natural menopause. For men, testosterone therapy is typically ongoing while it is helping and while labs stay in a safe range, but it is reviewed at every follow-up. Stopping is always a conversation, not a failure.
Can I start hormone therapy on my first visit?
Not usually, and that is intentional. The first visit is an evaluation: history, physical exam, blood pressure, and lab work. Testosterone in particular is generally confirmed on repeat morning testing before a diagnosis is made. Rushing a prescription before the workup is complete risks treating the wrong problem and missing a condition that needs different attention. Once results are back, your physician will review them with you and determine whether hormone therapy is appropriate and which form makes the most sense.
Will insurance cover hormone replacement therapy?
Coverage varies by plan, by which hormone is prescribed, and by whether the product is FDA-approved or compounded. Many FDA-approved estrogen, progesterone, and testosterone products are covered when there is a documented medical indication, while compounded preparations and some pellet therapies are frequently not. Lab work is often billed separately from office visits. The most reliable approach is to call our office at (404) 341-4819 with your insurance information before your visit so you know what to expect.
Want the full clinical detail? Read about our Hormone Replacement Therapy program.